Viratech Corp. (VIRA: OTC Pink Current) | Cancer Breath

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Viratech Corp. (VIRA: OTC Pink Current) | Cancer Breath Analysis Book; Best Seller on Amazon.com

CANCER BREATH ANALYSIS BOOK ACHIEVES BEST SELLER STATUS ON AMAZON.COM

S TOCKTON, CALIFORNIA/June 11, 2013 / Newswire/ -- Viratech Corp. (OTC:VIRA) announced today that Cancer.im?s  5 th    book of  235 books slated to be  released on Amazon?s Kindle platform, focusing on Cancer, has achieved best-seller status for Oncology.

The book, Breath Analysis for Detection of Diseases and their Causes by Dr. Kevin Buckman and Cancer Patient Advocate Chris Ryan, has achieved number 1 best-seller status for Oncology. The first book, Find and Stop Breast Cancer, became a best seller earlier this year after only three days. The book Breath Analysis for Detection of Diseases and their Causes  can be bought here:  http://www.amazon.com/Analysis-Detection-dise...541&sr=1-1

Breath Analysis for Detection of Diseases and their Causes is the result of decades of research in the field of cancer.

Breath analysis is a method for non-invasive tests on the clinical state of an individual by monitoring volatile organic compounds (VOC?s) present in the exhaled breath of humans and animals. Breath gas concentration can then be related to blood concentrations via calculations, for example in blood alcohol and other kinds of testing.

 Modern breath testing commenced in 1971, when Nobel Prize winner Linus Pauling demonstrated that human breath is a complex gas, with over 200 different volatile organic compounds.   Physicians have used breath analysis since the days of the ancient Greek scientists, and now there are some 3,481 compounds in breath exhalation that can be measured and more are being discovered. 

Volatile organic compounds (VOCs) are made inside the body from the human chemical system as a result of certain exposures to chemicals, normal metabolic activity, or due to disease states. They enter the body and are eventually metabolized or excreted via exhalation, skin emission, urine, sweat, tears, or other body fluids or secretions. 

Health care in the US now costs over $2 trillion a year.  Some health experts believe that we are now in a downward trend in our ability to cover health care costs.  Breath sampling is non-invasive and breath samples can be tested frequently due to low cost.  Finding of potential disease biomarkers can be obtained by analysis of exhaled breath.   There are many applications for medical diagnosis, finding the underlying problems with disease, all allow for therapy and prevention of disease and pre-disease states.   With frequent testing, this can allow for monitoring of various treatment options. 

According to the book, ?Cancer.im (www.cancer.im) is working to find new screening tests for cancer and new modes of therapy. The site, which launched on February 15, 2013, includes a user friendly Mission Adaptive Plan (a MAP) that can be tailored for each user, and 15 modules for dealing with the disease, which are based on the Robert Ryan Cancer Protocol . Based on more than 19 medical studies on quality of life and associated longevity, following the Robert Ryan Cancer Protocol decreases the morbidity of cancer by increasing the quality of life by the use of these 15 steps which allows a cancer patient to be proactive.  There is no charge for this service.? An explanatory video of the power of a Cancer Support Social Network can be seen here: http://www.youtube.com/watch?v=dz1tHRb3wvU

  About Cancer.im

Through its experience-based search engine and technology, Cancer.im's goal is to become the primary resource on the web for people affected by cancer, for the purpose of making a difference in their own lives and the lives of others.  Cancer.im?s mission is to empower every cancer patient with the ability to research their disease and to find, organize, and manage their own cancer support network at no charge to them. The goal of these support networks is to assist the patient in conserving needed energy by reducing the burden associated with their own daily trials and tribulations. Cancer.im will strive to convert this saved energy into a higher level of patient activity and a stronger determination to fight their disease.

In addition Cancer.im is seeking new cancer researchers who wish to leverage its intellectual property and social network platform for the purpose of creating new distribution and engagement channels.

  About Viratech Corp.

Viratech Corp. has created the first open source biotech research social network platform. The purpose of the platform is to make it possible for individuals or smaller companies to compete with larger companies in the race to patent new medicines or technology. This has been made possible by leveraging social collaboration in a way that allows new biotech ventures the ability to protect their intellectual property, then simultaneously allowing those same ventures the ability to promote and crowdsource their development.

Contact: Kevin Buckman MD

Viratech, Corp.

http://viratech.org

Email Contact: info@viratech.org

209-477-3030

 

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 295

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 112

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 196

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 98

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 176

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 184

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 210

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 168

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 137

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Long-Term Value Growth of Digital Realty Trust

Updated Category News Views 203

Digital Realty Trust: A 20-Year Journey of Growth Digital Realty Trust (NYSE: DLR) stands as a beacon of successful investing over the past two decades, consistently yielding remarkable returns. Rolling forward from the turn of the millennium to the current day, an investment made in this data center REIT has not just maintained its value but has outperformed traditional...

Continue Reading
Robotic Innovations Drive Future of Inspection and Maintenance Market

Updated Category News Views 187

Inspection and Maintenance Robots Market Overview The Inspection and Maintenance Robots Market is set to witness significant growth as industries embrace automation for improved efficiency and safety. According to market analysts, the size was valued at USD 41.66 billion in 2023 and is expected to soar to USD 146.9 billion by 2032, translating to a compound annual growth...

Continue Reading
Exploring the Growth of the Sports Analytics Market

Updated Category News Views 266

Understanding the Sports Analytics Market The Sports Analytics Market is experiencing notable expansion, primarily fueled by the rising demand for AI-driven analytics, the need for real-time performance insights, and enhanced strategies for player and team management. Despite its growth, challenges such as high implementation costs and data integration difficulties may...

Continue Reading
Exploring the Launch of Lit Protocol's Innovative AI Stack

Updated Category News Views 177

Revolutionizing AI with Lit Protocol's Decentralized Agent Stack Lit Protocol is inviting developers to harness the power of a decentralized AI agent stack that facilitates on-chain agents capable of autonomous transactions. This toolkit provides developers the ability to create these innovative agents, complete with wallet keys, enabling them to transact independently...

Continue Reading
Exploring the Promise of SKB264 in Cancer Treatments

Updated Category News Views 140

Introducing SKB264: A Major Breakthrough in Cancer Treatment SKB264, also referred to as MK-2870, signifies a significant leap in cancer therapy. This advanced antibody-drug conjugate (ADC) specifically targets TROP2 and is being developed through a collaboration between Kelun Biotech and MSD. Utilizing the state-of-the-art OptiDC platform, this therapy incorporates a...

Continue Reading